Antiretroviral drug resistance mutations in the reverse transcriptase gene of HIV-1 isolates from Northern Indian patients: A follow-up study

Archives of Virology

Volumn 155, Issue 4, 2010, Pages 563-569

  Choudhury, Shubhasree Dutta ^a   Chaudhury, Alok K ^a   Kalra, Rajesh ^a   Andrabi, Raiees ^a   Wig, Naveet ^a   Biswas, Ashutosh ^a   Bala, Manju ^b   Luthra, Kalpana ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b SAFDARJUNG HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

ANTIRETROVIRUS AGENT; REVERSE TRANSCRIPTASE, HUMAN IMMUNODEFICIENCY VIRUS 1; RNA DIRECTED DNA POLYMERASE;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ANTIVIRAL RESISTANCE; ARTICLE; CLUSTER ANALYSIS; DNA SEQUENCE; DRUG EFFECT; FEMALE; FOLLOW UP; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; MISSENSE MUTATION; MOLECULAR GENETICS; PHYLOGENY; SEQUENCE HOMOLOGY; VIROLOGY;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ANTI-RETROVIRAL AGENTS; CLUSTER ANALYSIS; DRUG RESISTANCE, VIRAL; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; INDIA; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PHYLOGENY; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; YOUNG ADULT;

EID: 77950611740     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-010-0605-4     Document Type: Article

References (15)

1. UNAIDS (2008) Report of the global AIDS epidemic. http://www. unaids. org/en/KnowledgeCentre/HIVData/GlobalReport/2008/Globalreport. asp. Accessed 15 Nov 2009.
2. Shafer RW, Schapiro JM (2008) HIV-1 drug resistance mutations: an updated framework for the second decade of HAART. AIDS Rev 10: 67-84.
3. Sala M, Vartanian JP (1998) HIV-1 reverse transcriptase: an out-of-the-ordinary enzyme. Bull Inst Pasteur 96: 49-63.
4. Kantor R, Katzenstein D (2004) Drug resistance in non-subtype B HIV-1. J Clin Virol 29: 152-159.
5. Arora SK, Gupta S, Toor JS, Singla A (2008) Drug resistance-associated genotypic alterations in the pol gene of HIV Type 1 isolates in ART-I individuals in North India. AIDS Res Hum Retroviruses 24: 125-130.
6. Hira SK, Panchal K, Parmar PA, Bhatia VP (2004) High resistance to antiretroviral drugs: the Indian experience. Int J STD AIDS 15: 173-177.
7. Soundararajan L, Karunaianandham R, Valerie J, Marie HS, Ranjani R, Paranji RN, Herve JF, Soumya S (2007) Characterization of HIV-1 isolates from antiretroviral Drug-I Children in Southern India. AIDS Res Hum Retroviruses 23: 119-1126.
8. Balakrishnan P, Kumarasamy N, Kantor R, Solomon S, Vidya S, Mayer KH (2005) HIV type 1 genotypic variation in an antiretroviral treatment-I population in southern India. AIDS Res Hum Retroviruses 21: 301-305.
9. Lall M, Gupta RM, Sen S, Kapila K, Tripathy SP, Paranjape RS (2008) Profile of primary resistance in HIV-1-infected treatment-I individuals from Western India. AIDS Res Hum Retroviruses 24: 987-990.
10. Shafer RW, Eisen JA, Merigan TC, Katzenstein DA (1997) Sequence and drug susceptibility of subtype C reverse transcriptase from human immunodeficiency virus Type 1 seroconverters in Zimbabwe. J Virol 71: 5441-5448.
11. Cano A, Monica V, Gonzalo A, Tzipe G, Maria EM, Eric G (2004) Antigenic properties of phage displayed peptides comprising disulfied-bonded loop of the immunodominant region of HIV-1 gp41. Immunol Lett 95: 207-212.
12. Eshleman SH, Hudelson SE, Gupta A, Bollinger R, Divekar AD, Gangakhedkar RR (2005) Limited evolution in the HIV type 1 pol region among acute seroconverters in Pune, India. AIDS Res Hum Retroviruses 21: 93-97.
13. Novak RM, Chen L, Mac Arthur RD (2005) Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected treatment I patients: implications for routine resistance screening before initiation of antiretroviral therapy. Clin Infect Dis 40: 468-474.
14. Sen S, Tripathy SP, Patil AA, Chimanpure VM, Paranjape RS (2007) High prevalence of human immunodeficiency virus Type 1 drug resistance mutations in antiretroviral treatment-experienced patients from Pune, India. AIDS Res Hum Retroviruses 23: 1303-1308.
15. Deshpande A, Jauvin V, Magnin N, Pinson P, Faure M, Masquelier B (2007) Resistance mutations in subtype C HIV type 1 isolates from Indian patients of Mumbai receiving NRTIs plus NNRTIs and experiencing a treatment failure: resistance to AR. AIDS Res Hum Retroviruses 23: 335-340.